by Maria Zannes | Apr 24, 2024 | Press Releases
bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth Collaboration with the US Department of Defense’s largest military health organization underway SAN ANTONIO, Texas (April 24, 2024) – bioAffinity Technologies,...
by Maria Zannes | Apr 9, 2024 | Press Releases
bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening SAN ANTONIO, Texas (April 9, 2024) – bioAffinity Technologies, Inc. (Nasdaq: BIAF and BIAFW) , a biotechnology company focused on the need for...
by Maria Zannes | Apr 1, 2024 | Press Releases
bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results SAN ANTONIO, Texas (April 1, 2024) – bioAffinity Technologies, Inc. (Nasdaq: BIAF and BIAFW) , a biotechnology company focused on commercializing noninvasive tests for the detection...
by Maria Zannes | Mar 8, 2024 | Press Releases
bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement SAN ANTONIO, Texas (March 5, 2024) – bioAffinity Technologies, Inc. (Nasdaq: BIAF and BIAFW) today announced it has closed a securities purchase...
by Maria Zannes | Mar 6, 2024 | Press Releases
bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement SAN ANTONIO, Texas (March 5, 2024) – bioAffinity Technologies, Inc. (Nasdaq: BIAF and BIAFW) today announced it has entered into a securities...
